DK1335689T3 - System til transdermal indgivelse af loratadin og anvendelse deraf - Google Patents

System til transdermal indgivelse af loratadin og anvendelse deraf

Info

Publication number
DK1335689T3
DK1335689T3 DK01997122.5T DK01997122T DK1335689T3 DK 1335689 T3 DK1335689 T3 DK 1335689T3 DK 01997122 T DK01997122 T DK 01997122T DK 1335689 T3 DK1335689 T3 DK 1335689T3
Authority
DK
Denmark
Prior art keywords
loratadine
transdermal administration
administration system
urticariain
tansdermal
Prior art date
Application number
DK01997122.5T
Other languages
English (en)
Inventor
Lino Tavares
Ihor Shevchuk
Mark Alfonso
Geraldine Marcenyac
Kirti H Valia
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1335689T3 publication Critical patent/DK1335689T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01997122.5T 2000-10-23 2001-10-23 System til transdermal indgivelse af loratadin og anvendelse deraf DK1335689T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24251500P 2000-10-23 2000-10-23
PCT/US2001/050205 WO2002058608A1 (en) 2000-10-23 2001-10-23 Loratadine transdermal device and methods

Publications (1)

Publication Number Publication Date
DK1335689T3 true DK1335689T3 (da) 2010-06-14

Family

ID=22915072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01997122.5T DK1335689T3 (da) 2000-10-23 2001-10-23 System til transdermal indgivelse af loratadin og anvendelse deraf

Country Status (6)

Country Link
US (1) US9259397B2 (da)
EP (1) EP1335689B1 (da)
AT (1) ATE460928T1 (da)
DE (1) DE60141596D1 (da)
DK (1) DK1335689T3 (da)
WO (1) WO2002058608A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
DE10360592A1 (de) * 2003-12-19 2005-07-28 Beiersdorf Ag Pflastersystem zur Verabreichung von Antihistaminika
US20060224056A1 (en) * 2005-03-30 2006-10-05 Kermani Mahyar Z Method for monitoring an implanted fluorescent light-emitting bead
US20060229507A1 (en) * 2005-03-30 2006-10-12 Kermani Mahyar Z Adhesive fluorescence measurement band
US20060229508A1 (en) * 2005-03-30 2006-10-12 Kermani Mahyar Z Adhesive fluorescence measurement patch
US20060224055A1 (en) * 2005-03-30 2006-10-05 Kermani Mahyar Z Fluorescence measurement analytical kit
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US5045319A (en) * 1985-02-25 1991-09-03 Rutgers, The State University Of New Jersey Transdermal dosage unit, system and process
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5240711A (en) 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
EP0484543B1 (en) 1990-04-24 1995-12-13 Teijin Limited Plaster
DE4110027C2 (de) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE4446600A1 (de) 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
JP2001503749A (ja) * 1996-10-30 2001-03-21 セラテック・インコーポレーテッド 透過促進剤としてのグリコール酸の脂肪酸エステル及びその塩
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5879701A (en) 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
US6103735A (en) * 1998-10-09 2000-08-15 Schering Corporation Composition and method for treating allergic diseases

Also Published As

Publication number Publication date
DE60141596D1 (de) 2010-04-29
EP1335689A1 (en) 2003-08-20
ATE460928T1 (de) 2010-04-15
WO2002058608A1 (en) 2002-08-01
EP1335689B1 (en) 2010-03-17
US9259397B2 (en) 2016-02-16
US20030035828A1 (en) 2003-02-20
EP1335689A4 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
NO20023225D0 (no) Fremgangsmåte og krets for å benytte polarisert anordning i vekselströmapplikasjoner
DK1519770T3 (da) Elektroporesisk indretning og indsprøjtningsapparat
NO20032506L (no) Koplingsisolasjonsanordning og fremgangsmåte til bruk i multilateralbrönnbehandlingsoperasjon
HUP0203529A2 (hu) Dezloratadin alkalmazása alvászavarok kezelésére
NO20011964D0 (no) Brönnbehandlingsfluider og fremgangsmåter med anvendelse derav
DK1298282T3 (da) Fremgangsmåde og indretning til syrebehandling af en underjordisk formation i borehuller
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
NO20030677D0 (no) Nye aporfinestere og deres anvendelse i terapi
DE60320530D1 (de) Missbrauchssichere transdermale opioid-verabreichungsvorrichtungen
NO20012755D0 (no) Klemme og rörhåndteringsanordning
EP1691686A4 (en) Tinnitus rehabilitation device and method
NO20012199L (no) Innkapslede kjemikalier for anvendelse i kontrollert tid frigivelsesapplikasjoner og fremgangsmåter
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
NO20024310D0 (no) Nye CCR5-modulatorer: benzimidazoler og benzotriazoler
ITFI20000198A0 (it) Dispositivo e metodo per il trasporto molecolare transdermico
DK1335689T3 (da) System til transdermal indgivelse af loratadin og anvendelse deraf
NO20042612L (no) Preparat for potensiering av et opiatanalgetikum og anvendelse derav for behandling av smerte hos et pattedyr.
DK1592408T3 (da) Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af adrenergt midler
DK1827274T3 (da) Kryokirurgiindretning og fremgangsmåde til afgivelse af et flydende kølemiddel
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
BR0016138B1 (pt) formulaÇço farmacÊutica adequada para a administraÇço intranasal, uso de zolmitriptan, e, dispositivo de administraÇço intranasal
DK1139187T3 (da) Fremgangsmåde og indretning til vækning
DE60116488D1 (de) Fadenliefervorrichtung und -verfahren
DK1467762T3 (da) Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis
NO20024428D0 (no) Brönnkompletteringsanordning med et strömningsforsikringssystem, og tilknyttede fremgangsmåter